Amanta Healthcar — 360° view

Amanta Healthcar, a company in the Pharmaceuticals industry, reported revenue of ₹83 crore and net profit of ₹4.86 crore for the September 2026 quarter.

Amanta Healthcar (NSE: AMANTA) closed at ₹222.37 on 20 Nov 2026, up 90.3% over the past year. Its market capitalisation is ₹863 crore and it trades at 47.1 times earnings.

Share price
₹222.37 (20 Nov 2026)
Market cap
₹863 Cr (20 Nov 2026)
P/E
47.11 (20 Nov 2026)
Revenue
₹83 Cr (September 2026 quarter)
Net profit
₹5 Cr (September 2026 quarter)
ROCE
11.6% (FY26)
ROE
10.3% (FY26)
Book value
₹58.8 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹245.70 / ₹92.00 (20 Nov 2026)
1-year return
90.3% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: AMANTA

Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.